The device screens for conditions like diabetic retinopathy, glaucoma, age-related macular degeneration, cataract and refractive error, in under ten minutes per patient
PAT soars 201%, EBITDA up 88% on strong PHPO demand & margin expansion
The platform created by NIT Rourkela researchers is capable of delivering rapid, accurate, and repeatable imaging results with minimal human intervention
Hikal’s Q4 profit remained sharply lower year-on-year, falling 71% from Rs. 50.2 crore in Q4 FY25 as the company absorbed regulatory pressures and strategic accounting adjustments
The company is set to unveil new clinical data across obesity, diabetes, kidney, and liver disease programs
The Establishment Inspection Report came following closure of a product- specific pre-approval inspection from March 2 to March 7, 2026
Honoured for his immense contribution in the field of social service and organ donation awareness
These data support clinically meaningful efficacy within this patient population. We observed a high rate of complete responses in patients with laCSCC
The company highlighted continued demand strength and pricing resilience despite global disruptions
POSEIDON is among the largest global datasets to quantify this residual inflammatory burden
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
